Bernd Büttelmann

744 total citations
13 papers, 519 citations indexed

About

Bernd Büttelmann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Bernd Büttelmann has authored 13 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in Bernd Büttelmann's work include Neuroscience and Neuropharmacology Research (11 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Receptor Mechanisms and Signaling (4 papers). Bernd Büttelmann is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Receptor Mechanisms and Signaling (4 papers). Bernd Büttelmann collaborates with scholars based in Switzerland and Germany. Bernd Büttelmann's co-authors include Vincent Mutel, Georg Jaeschke, Richard H. Porter, Eric Prinssen, Sabine Kolczewski, Eric Vieira, Will Spooren, S. Gatti, Jürgen Wichmann and Theresa M. Ballard and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Bioorganic & Medicinal Chemistry Letters and Heterocycles.

In The Last Decade

Bernd Büttelmann

13 papers receiving 507 citations

Peers

Bernd Büttelmann

CMN

GENET

Richard G. Boles United States

Pete H. Hutson United States

Berthold Behl Germany

Martin B. Gill United States

Timothy Johnstone United States

Frances A. Bromidge United Kingdom

Lara Costa Italy

Silvio Ofner Switzerland

Sabine Kolczewski Switzerland

Ken H. Ho United States

Richard G. Boles United States

Bernd Büttelmann

304 ×0.9

CMN

261 ×0.8

73 ×0.8

45 ×0.6

29 ×0.4

GENET

Citations per year, relative to Bernd Büttelmann Bernd Büttelmann (= 1×) peers Richard G. Boles

Countries citing papers authored by Bernd Büttelmann

Since Specialization

Citations

This map shows the geographic impact of Bernd Büttelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Büttelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Büttelmann more than expected).

Fields of papers citing papers by Bernd Büttelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Büttelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Büttelmann. The network helps show where Bernd Büttelmann may publish in the future.

Co-authorship network of co-authors of Bernd Büttelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Büttelmann. A scholar is included among the top collaborators of Bernd Büttelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Büttelmann. Bernd Büttelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lindemann, Lothar, Georg Jaeschke, Aubin Michalon, et al.. (2011). CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 339(2). 474–486. 91 indexed citations

Ballard, Theresa M., Francesca Blasco, Pierre‐Emmanuel Broutin, et al.. (2009). Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABAA α5 inverse agonist series. Bioorganic & Medicinal Chemistry Letters. 19(19). 5746–5752. 23 indexed citations

Jaeschke, Georg, Richard H. Porter, Bernd Büttelmann, et al.. (2006). Synthesis and biological evaluation of fenobam analogs as mGlu5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(5). 1307–1311. 14 indexed citations

Büttelmann, Bernd, Jens‐Uwe Peters, Simona Ceccarelli, et al.. (2006). Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(7). 1892–1897. 8 indexed citations

Porter, Richard H., Georg Jaeschke, Will Spooren, et al.. (2005). Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity. Journal of Pharmacology and Experimental Therapeutics. 315(2). 711–721. 246 indexed citations

Büttelmann, Bernd, Alexander Alanine, Anne Bourson, et al.. (2003). 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(5). 829–832. 18 indexed citations

Büttelmann, Bernd, Alexander Alanine, Anne Bourson, et al.. (2003). 4-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(10). 1759–1762. 11 indexed citations

Alanine, Alexander, Anne Bourson, Bernd Büttelmann, et al.. (2003). 1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(19). 3155–3159. 21 indexed citations

Gill, R., Alexander Alanine, Anne Bourson, et al.. (2002). Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-d-Aspartate Antagonist. Journal of Pharmacology and Experimental Therapeutics. 302(3). 940–948. 45 indexed citations

10.

Pinard, Emmanuel, Alexander Alanine, Anne Bourson, et al.. (2002). 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(18). 2615–2619. 21 indexed citations

11.

Pinard, Emmanuel, Alexander Alanine, Anne Bourson, et al.. (2001). Discovery of (R)-1-[2-Hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: A Novel NR1/2B Subtype Selective NMDA Receptor Antagonist. Bioorganic & Medicinal Chemistry Letters. 11(16). 2173–2176. 14 indexed citations

12.

Büttelmann, Bernd, et al.. (1996). Synthesis and Rearrangement of 6H-Imidazo[1,2-c]quinazolin-5-ones. Heterocycles. 43(12). 2607–2607. 3 indexed citations

13.

Mulzer, Johann, et al.. (1988). Synthesis of diastereomerically and enantiomerically pure (3S,4S)‐statine. Liebigs Annalen der Chemie. 1988(5). 445–448. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact